ask="8.80"
ask_size="700"
average_daily_volume="88577"
bid="5.90"
bid_size="500"
book_value="5.08"
change="+0.08"
change_from_200_day_moving_average="1.24"
change_from_50_day_moving_average="1.83"
change_from_52_week_high="-5.75"
change_From_52_week_low="3.34"
change_in_percent="+1.16%"
close="7.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-3.75"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="6295000"
high="7.05"
high_52_weeks="12.75"
last_trade_date="3/14/2017"
last_trade_price="7.00"
last_trade_size="100"
last_trade_time="3:59pm"
low="6.77"
low_52_weeks="3.66"
market_capitalization="94.01M"
moving_average_200_day="5.76"
moving_average_50_day="5.17"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="16.33"
open="6.88"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+21.59%"
percent_change_from_50_day_moving_average="+35.36%"
percent_change_from_52_week_high="-45.10%"
percent_change_from_52_week_low="+91.26%"
previous_close="6.92"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.36"
price_per_sales="18.71"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="0.50"
stock_exchange="NGM"
symbol="AGLE"
volume="81626"
weeks_range_52="3.66 - 12.75"
